Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
about
Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@ast
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@en
type
label
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@ast
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@en
prefLabel
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@ast
Efficacy and safety at 24 week ...... nts with rheumatoid arthritis.
@en
P2093
P2860
P1433
P1476
Efficacy and safety at 24 week ...... ents with rheumatoid arthritis
@en
P2093
Atsushi Kawakami
Ayako Nishino
Ayuko Takatani
Hideki Nakamura
Kaoru Terada
Katsumi Eguchi
Mami Tamai
Masataka Umeda
Shin-Ya Kawashiri
Shoichi Fukui
P2860
P304
P356
10.1371/JOURNAL.PONE.0177057
P407
P577
2017-05-04T00:00:00Z